Health and Healthcare Systems

5 questions you might have on COVID vaccines, answered by the WHO

image of the Astrazeneca COVID-19 vaccine

Israel is leading the way with vaccination rates, followed by the United Arab Emirates.

Image: REUTERS/Raneen Sawafta

  • Major scientific breakthroughs coupled with unprecedented cooperation and investment means we now have several vaccines approved for use.
  • To date, Israel is leading the way by number of vaccines per capita.
  • The World Health Organization has produced a video to answer some of the most common questions about the coronavirus vaccines.

A year ago, even the most optimistic among us would have found it hard to believe we would have a vaccine against the pandemic that was starting to grip the world. Now we have several. And millions of people have received at least one dose.

It is a major scientific achievement, coupled with unprecedented international cooperation and investment, that has got us to this point. Previous vaccines have taken around 10 years to develop.

a chart showing the countries with the highest rate of COVID-19 vaccination
Israel leads with the highest rate of COVID-19 vaccination. Image: Statista
Discover

How has the Forum navigated the global response to COVID-19?

As more and more of us are invited to get our vaccine, it is natural that people might have some questions. From whether we need both doses, to the jabs’ effectiveness against new and emerging variants, in this World Health Organization video, Professor Katherine O’Brien answers five of the most common questions.

Accept our marketing cookies to access this content.

These cookies are currently disabled in your browser.

Accept our marketing cookies to access this content.

These cookies are currently disabled in your browser.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.